1. Home
  2. L vs NTRA Comparison

L vs NTRA Comparison

Compare L & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • L
  • NTRA
  • Stock Information
  • Founded
  • L 1969
  • NTRA 2003
  • Country
  • L United States
  • NTRA United States
  • Employees
  • L N/A
  • NTRA N/A
  • Industry
  • L Property-Casualty Insurers
  • NTRA Medical Specialities
  • Sector
  • L Finance
  • NTRA Health Care
  • Exchange
  • L Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • L 20.0B
  • NTRA 21.7B
  • IPO Year
  • L N/A
  • NTRA 2015
  • Fundamental
  • Price
  • L $96.79
  • NTRA $175.43
  • Analyst Decision
  • L
  • NTRA Strong Buy
  • Analyst Count
  • L 0
  • NTRA 16
  • Target Price
  • L N/A
  • NTRA $193.50
  • AVG Volume (30 Days)
  • L 712.2K
  • NTRA 914.8K
  • Earning Date
  • L 11-03-2025
  • NTRA 11-11-2025
  • Dividend Yield
  • L 0.26%
  • NTRA N/A
  • EPS Growth
  • L N/A
  • NTRA N/A
  • EPS
  • L 6.28
  • NTRA N/A
  • Revenue
  • L $18,061,000,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • L N/A
  • NTRA $23.93
  • Revenue Next Year
  • L N/A
  • NTRA $15.60
  • P/E Ratio
  • L $15.28
  • NTRA N/A
  • Revenue Growth
  • L 8.27
  • NTRA 44.38
  • 52 Week Low
  • L $75.16
  • NTRA $117.27
  • 52 Week High
  • L $98.33
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • L 55.59
  • NTRA 62.27
  • Support Level
  • L $95.71
  • NTRA $167.00
  • Resistance Level
  • L $98.33
  • NTRA $176.82
  • Average True Range (ATR)
  • L 1.12
  • NTRA 5.06
  • MACD
  • L -0.18
  • NTRA 0.13
  • Stochastic Oscillator
  • L 52.17
  • NTRA 86.08

About L Loews Corporation

Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: